Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal

British Journal of Pharmacology

Volumn 151, Issue 6, 2007, Pages 787-797

  Almela, P ^a   Milanes M V ^a   Laorden, M L ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

c Fos; ERK; Heart; Morphine withdrawal; Naloxone; SL327

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; ONCOGENE C FOS; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

AMINOACETONITRILE; ANIMALS; BLOTTING, WESTERN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; GENES, FOS; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; MALE; MAP KINASE SIGNALING SYSTEM; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34447552511     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707301     Document Type: Article

References (34)

1. Almela P, Cerezo M, Milanés MV, Laorden ML (2006). Role of PKC in regulating of Fos and TH expression after naloxone induced morphine withdrawal in the heart. Naunyn Schmiedebergs Arch Pharmacol 372: 374-382.
2. Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD (1998). The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1: 602-609.
3. Benavides M, Laorden ML, Milanés MV (2003). Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PNV and medulla oblongata catecholaminergic cell groups innervating the PVN. Eur J Neurosci 17: 103-112.
4. Berhow M, Hiroi N, Nestler EJ (1996). Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16: 4707-4715.
5. Berhow MT, Russel DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM et al. (1995). Influence of neurotrophic factor on morphine-and cocaine induced biochemical changes in the mesolimbic dopamine system. Neurosci 68: 969-979.
6. Cao JL, He JH, Ding HL, Zeng YM (2005). Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. Pain 118: 336-349.
7. Ebisuya M, Kondoh K, Nishida E (2005). The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specifity. J Cell Sci 118: 2997-3002.
8. Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Keith D et al. (2003). Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activaton during analgesic tolerance and locomotor sensitization. J Neursci 23: 8360-8369.
9. Fuertes G, Laorden ML, Milanés MV (2000). Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal. Neuroendocrinology 71: 60-67.
10. González-Cuello A, Milanés MV, Avíles M, Laorden ML (2004a). Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 370: 17-25.
11. González-Cuello A, Milanés MV, Castells MT, Laorden ML (2003). Activation c-fos expression in the heart after morphine but not U-50,488H withdrawal. Br J Pharmacol 138: 626-633.
12. González-Cuello A, Milanés MV, Laorden ML (2004b). Increase of tyrosine hydroxylase levels and activity during morphine withdrawal in the heart. Eur J Pharmacol 506: 119-128.
13. Haycock JW (1993). Multiple signaling pathways in bobine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, ser31, ser40. Neurochem Res 18: 15-26.
14. Koob GF, Sanna PP, Bloom FE (1998). Neuroscience of addiction. Neuron 21: 467-476.
15. Kreek MJ, Koob GF (1998). Drug dependence stress and dysregulation of brain reward pathways. Drug Alchohol Depend 51: 23-47.
16. Laorden ML, Castells MT, Milanés MV (2002a). Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats. Br J Pharmacol 136: 67-75.
17. Laorden ML, Fuertes G, González-Cuello A, Milanés MV (2000). Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of a1 and a2 adrenoceptors. J Pharmacol Exp Ther 293: 578-584.
18. Laorden ML, Nuñez C, Almela P, Milanés MV (2002b). Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones. J Neurochemistry 83: 132-140.
19. Lesscher HMB, Burbach JPH, Van Ree JM, Gerrits MAFM, Aantaa R (2003). ERK1/2 activation in rat ventral tegmental area by the mu-opioid agonist fentanyl: An in vitro study. Neuroscience 116: 139-144.
20. Liu JG, Anand KJ (2001). Protein kinase modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38: 1-19.
21. Martínez MD, Milanés MV, Laorden ML (2003). Implication of the signal transduction pathways in the enhancement of noradrenaline turnover induced by morphine withdrawal in the heart. Eur J Pharmacol 471: 113-119.
22. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W et al. (2002). Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron 34: 807-820.
23. Milanés MV, Laorden ML (2000). Changes in catecholaminergic pathways innervating the rat heart ventricle during morphine dependence. Involvement of a1 and a2 adrenoreceptors. Eur J Pharmacol 397: 311-318.
24. Milanés MV, Martínez MD, González-Cuello A, Laorden ML (2001). Evidence for a peripheral mechanism in cardiac opioid withdrawal. Naunyn Schmiedebergs Arch Pharmacol 364: 193-198.
25. Milanés MV, Fuente T, Laorden ML (2000). Catecholaminergic activity and 30,50-cyclic adenosine monophosphate levels in heart right ventricle after naloxone induced withdrawal. Naunyn Schmiedebergs Arch Pharmacol 361: 61-66.
26. Monje P, Hernández-Losa J, Lyons RJ, Castellone MD, Gutkind JS (2005). Regulation of the trnscriptional activity of c-Fos y ERK: a novel role for the prolyl isomerase pin1. J Biol Chem 280: 35081-35084.
27. Muller DL, Unterwald EM (2004). In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther 3010: 774-782.
28. Nestler EJ (2004). Molecular mechanisms of drug addiction. Neuropharmacology 47: 24-32.
29. Nestler EJ, Aghajanian CK (1997). Molecular and cellular basis of addiction. Science 278: 58-63.
30. Ozaki S, Narita M, Ozaki M, Khotib J, Suzuki T (2004). Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppresion of the morphine-induced rewarding effect in mice with sciatic nerve ligation. J Neurochem 88: 1389-1397.
31. Rabadán JV, Milanés MV, Laorden ML (1997). Effects of chronic morphine treatment on catecholamines content and mechanical response in the rat heart. J Pharmacol Exp Ther 280: 32-37.
32. Ren X, Noda Y, Mamiya T, Nagai T, Nabeshima T (2004). A neuroactive steroid, dehydroepiandreosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Beh Brain Res 152: 243-250.
33. Valjent E, Pages C, Herve D, Girault JA, Caboche J (2004). Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain. Eur J Neurosci 19: 1826-1836.
34. Yang SH, Sharrocks AD, Whitmarsh AJ (2003). Transcriptional regulation by the MAP kinase signalling cascade. Gene 320: 3-21.